• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肽类作为治疗药物:绿色转型时代的挑战与机遇。

Peptides as Therapeutic Agents: Challenges and Opportunities in the Green Transition Era.

机构信息

Department of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy.

Department of Health Sciences, University "Magna Graecia", Viale Europa, 88100 Catanzaro, Italy.

出版信息

Molecules. 2023 Oct 19;28(20):7165. doi: 10.3390/molecules28207165.

DOI:10.3390/molecules28207165
PMID:37894644
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10609221/
Abstract

Peptides are at the cutting edge of contemporary research for new potent, selective, and safe therapeutical agents. Their rise has reshaped the pharmaceutical landscape, providing solutions to challenges that traditional small molecules often cannot address. A wide variety of natural and modified peptides have been obtained and studied, and many others are advancing in clinical trials, covering multiple therapeutic areas. As the demand for peptide-based therapies grows, so does the need for sustainable and environmentally friendly synthesis methods. Traditional peptide synthesis, while effective, often involves environmentally draining processes, generating significant waste and consuming vast resources. The integration of green chemistry offers sustainable alternatives, prioritizing eco-friendly processes, waste reduction, and energy conservation. This review delves into the transformative potential of applying green chemistry principles to peptide synthesis by discussing relevant examples of the application of such approaches to the production of active pharmaceutical ingredients (APIs) with a peptide structure and how these efforts are critical for an effective green transition era in the pharmaceutical field.

摘要

肽是当代新型高效、选择性和安全治疗药物研究的前沿领域。它们的出现改变了药物研发的格局,为传统小分子药物难以解决的问题提供了新的解决方案。已经获得并研究了各种各样的天然和修饰肽,还有许多其他肽正在临床试验中进行,涵盖了多个治疗领域。随着对基于肽的治疗方法的需求不断增长,对可持续和环保的合成方法的需求也在增加。传统的肽合成虽然有效,但往往涉及到环境消耗性的过程,产生大量的废物并消耗大量的资源。绿色化学的整合提供了可持续的替代方案,优先考虑环保的过程、废物减少和能源节约。本文通过讨论将这些方法应用于具有肽结构的活性药物成分(API)生产的相关实例,深入探讨了将绿色化学原则应用于肽合成的变革潜力,以及这些努力对于制药领域有效绿色转型时代的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/5c8d0add6a6a/molecules-28-07165-g024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/af4fd4dcc89e/molecules-28-07165-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/4e8419f636b4/molecules-28-07165-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/2deb081c0c43/molecules-28-07165-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/6bf7c6d3f39d/molecules-28-07165-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/93e8bc9e3b28/molecules-28-07165-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/5b8870770552/molecules-28-07165-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/fa269e83b3e2/molecules-28-07165-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/309073f82e68/molecules-28-07165-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/35e0ac1f6035/molecules-28-07165-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/c047dfce44aa/molecules-28-07165-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/acd6a424564d/molecules-28-07165-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/82633ac1ef59/molecules-28-07165-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/353c5d8f496b/molecules-28-07165-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/9929fed27b8e/molecules-28-07165-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/15df28a0be8e/molecules-28-07165-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/df558a0281c3/molecules-28-07165-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/d82668408570/molecules-28-07165-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/d7622c38bc78/molecules-28-07165-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/39fa5bf6ecf8/molecules-28-07165-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/37f8ba35ea4e/molecules-28-07165-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/1d0c7a0bc27b/molecules-28-07165-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/c769a1e9d061/molecules-28-07165-g022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/63e8fa01d488/molecules-28-07165-g023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/5c8d0add6a6a/molecules-28-07165-g024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/af4fd4dcc89e/molecules-28-07165-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/4e8419f636b4/molecules-28-07165-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/2deb081c0c43/molecules-28-07165-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/6bf7c6d3f39d/molecules-28-07165-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/93e8bc9e3b28/molecules-28-07165-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/5b8870770552/molecules-28-07165-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/fa269e83b3e2/molecules-28-07165-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/309073f82e68/molecules-28-07165-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/35e0ac1f6035/molecules-28-07165-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/c047dfce44aa/molecules-28-07165-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/acd6a424564d/molecules-28-07165-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/82633ac1ef59/molecules-28-07165-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/353c5d8f496b/molecules-28-07165-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/9929fed27b8e/molecules-28-07165-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/15df28a0be8e/molecules-28-07165-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/df558a0281c3/molecules-28-07165-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/d82668408570/molecules-28-07165-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/d7622c38bc78/molecules-28-07165-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/39fa5bf6ecf8/molecules-28-07165-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/37f8ba35ea4e/molecules-28-07165-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/1d0c7a0bc27b/molecules-28-07165-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/c769a1e9d061/molecules-28-07165-g022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/63e8fa01d488/molecules-28-07165-g023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e36/10609221/5c8d0add6a6a/molecules-28-07165-g024.jpg

相似文献

1
Peptides as Therapeutic Agents: Challenges and Opportunities in the Green Transition Era.肽类作为治疗药物:绿色转型时代的挑战与机遇。
Molecules. 2023 Oct 19;28(20):7165. doi: 10.3390/molecules28207165.
2
Process Mass Intensity (PMI): A Holistic Analysis of Current Peptide Manufacturing Processes Informs Sustainability in Peptide Synthesis.过程质量数(PMI):对当前肽生产工艺的整体分析为肽合成的可持续性提供了信息。
J Org Chem. 2024 Apr 5;89(7):4261-4282. doi: 10.1021/acs.joc.3c01494. Epub 2024 Mar 20.
3
Amide Bonds Meet Flow Chemistry: A Journey into Methodologies and Sustainable Evolution.酰胺键与流动化学相遇:方法学与可持续发展的探索之旅。
ChemSusChem. 2022 Mar 22;15(6):e202102708. doi: 10.1002/cssc.202102708. Epub 2022 Feb 1.
4
Peptide chemistry toolbox - Transforming natural peptides into peptide therapeutics.肽化学工具箱——将天然肽转化为肽类治疗药物。
Bioorg Med Chem. 2018 Jun 1;26(10):2759-2765. doi: 10.1016/j.bmc.2018.01.012. Epub 2018 Jan 31.
5
Making Solid-Phase Peptide Synthesis Greener: A Review of the Literature.固相多肽合成的绿色化:文献综述。
Chem Asian J. 2019 Apr 15;14(8):1088-1097. doi: 10.1002/asia.201801807. Epub 2019 Feb 20.
6
Inverse Peptide Synthesis Using Transient Protected Amino Acids.使用瞬时保护氨基酸进行反肽合成。
J Am Chem Soc. 2024 Feb 14;146(6):4270-4280. doi: 10.1021/jacs.4c00314. Epub 2024 Feb 5.
7
Linking mechanochemistry with the green chemistry principles: Review article.将机械化学与绿色化学原则相联系:综述文章。
Heliyon. 2024 Jul 15;10(14):e34655. doi: 10.1016/j.heliyon.2024.e34655. eCollection 2024 Jul 30.
8
Silylated Tag-Assisted Peptide Synthesis: Continuous One-Pot Elongation for the Production of Difficult Peptides under Environmentally Friendly Conditions.硅烷化标签辅助肽合成:在环境友好条件下连续一锅法延伸合成难合成的肽
Molecules. 2021 Jun 8;26(12):3497. doi: 10.3390/molecules26123497.
9
Sustainability Challenges in Peptide Synthesis and Purification: From R&D to Production.多肽合成与纯化中的可持续性挑战:从研发到生产。
J Org Chem. 2019 Apr 19;84(8):4615-4628. doi: 10.1021/acs.joc.8b03001. Epub 2019 Mar 22.
10
Dipropyleneglycol Dimethylether, New Green Solvent for Solid-Phase Peptide Synthesis: Further Challenges to Improve Sustainability in the Development of Therapeutic Peptides.二丙二醇二甲醚,用于固相肽合成的新型绿色溶剂:治疗性肽开发中提高可持续性面临的进一步挑战。
Pharmaceutics. 2023 Jun 20;15(6):1773. doi: 10.3390/pharmaceutics15061773.

引用本文的文献

1
From concept to chemistry: integrating protection group strategy and reaction feasibility into non-natural amino acid synthesis planning.从概念到化学:将保护基策略和反应可行性整合到非天然氨基酸合成规划中。
Chem Sci. 2025 Sep 8. doi: 10.1039/d5sc04898b.
2
Computational and experimental discovery of peptide inhibitors targeting survivin for therapeutic potential in cancer.靶向生存素的肽抑制剂的计算与实验发现及其在癌症治疗中的潜力
Sci Rep. 2025 Aug 20;15(1):30599. doi: 10.1038/s41598-025-13110-3.
3
Mucoadhesive Mini-Containers with Unidirectional Drug Release Capacity for Macromolecular Therapeutics.

本文引用的文献

1
2022 FDA TIDES (Peptides and Oligonucleotides) Harvest.2022年美国食品药品监督管理局潮汐项目(肽与寡核苷酸)成果
Pharmaceuticals (Basel). 2023 Feb 22;16(3):336. doi: 10.3390/ph16030336.
2
cRGD-Functionalized Silk Fibroin Nanoparticles: A Strategy for Cancer Treatment with a Potent Unselective Naphthalene Diimide Derivative.cRGD功能化丝素蛋白纳米颗粒:一种使用强效非选择性萘二亚胺衍生物进行癌症治疗的策略。
Cancers (Basel). 2023 Mar 11;15(6):1725. doi: 10.3390/cancers15061725.
3
Medicinal chemistry insights into antiviral peptidomimetics.抗病毒拟肽药物的药物化学见解。
具有单向药物释放能力的用于大分子治疗的粘膜粘附微型容器
Drug Des Devel Ther. 2025 Aug 1;19:6619-6635. doi: 10.2147/DDDT.S521900. eCollection 2025.
4
Characterizing and engineering post-translational modifications with high-throughput cell-free expression.利用高通量无细胞表达技术对翻译后修饰进行表征和工程改造。
Nat Commun. 2025 Aug 5;16(1):7215. doi: 10.1038/s41467-025-60526-6.
5
A hybrid framework of generative deep learning for antiviral peptide discovery.用于抗病毒肽发现的生成式深度学习混合框架。
Sci Rep. 2025 Jul 15;15(1):25554. doi: 10.1038/s41598-025-11328-9.
6
Effects of Peptides and Bioactive Peptides on Acute Kidney Injury: A Review Study.肽和生物活性肽对急性肾损伤的影响:一项综述研究。
Iran Biomed J. 2025 Jul 1;29(3):1-5. doi: 10.61186/ibj.5000.
7
The Role of Peptides in Nutrition: Insights into Metabolic, Musculoskeletal, and Behavioral Health: A Systematic Review.肽在营养中的作用:对代谢、肌肉骨骼和行为健康的见解:一项系统综述。
Int J Mol Sci. 2025 Jun 24;26(13):6043. doi: 10.3390/ijms26136043.
8
Computational exploration of global venoms for antimicrobial discovery with Venomics artificial intelligence.利用毒液组学人工智能对抗菌药物发现进行全球毒液的计算探索。
Nat Commun. 2025 Jul 12;16(1):6446. doi: 10.1038/s41467-025-60051-6.
9
Versatile enhancement of the killing potential of anti-cancer agents achieved by peptide mimetics of the PCNA interface towards specialized DNA polymerases.通过增殖细胞核抗原(PCNA)界面的肽模拟物对特定DNA聚合酶实现抗癌药物杀伤潜力的多功能增强。
Cell Death Dis. 2025 Jul 8;16(1):503. doi: 10.1038/s41419-025-07812-9.
10
Beyond Molecular Weight: Peptide Characteristics Influencing the Sensitivity of Retention to Changes in Organic Solvent in Reversed-Phase Chromatography.超越分子量:影响反相色谱中保留对有机溶剂变化敏感性的肽段特征
ACS Omega. 2025 Jun 17;10(25):27089-27097. doi: 10.1021/acsomega.5c02327. eCollection 2025 Jul 1.
Drug Discov Today. 2023 Mar;28(3):103468. doi: 10.1016/j.drudis.2022.103468. Epub 2022 Dec 14.
4
Peptidomimetics in cancer targeting.癌症靶向的肽模拟物。
Mol Med. 2022 Dec 7;28(1):146. doi: 10.1186/s10020-022-00577-3.
5
Antimicrobial peptides with anticancer activity: Today status, trends and their computational design.具有抗癌活性的抗菌肽:当前状况、趋势及其计算机辅助设计
Arch Biochem Biophys. 2023 Jan 1;733:109484. doi: 10.1016/j.abb.2022.109484. Epub 2022 Dec 5.
6
Anticancer effect of rationally designed α-helical amphiphilic peptides.合理设计的α-螺旋两亲肽的抗癌作用。
Colloids Surf B Biointerfaces. 2022 Dec;220:112841. doi: 10.1016/j.colsurfb.2022.112841. Epub 2022 Sep 19.
7
Absolute binding free energies of mucroporin and its analog mucroporin-M1 with the heptad repeat 1 domain and RNA-dependent RNA polymerase of SARS-CoV-2.微小孔蛋白及其类似物微小孔蛋白-M1与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的七肽重复序列1结构域和RNA依赖性RNA聚合酶的绝对结合自由能。
J Biomol Struct Dyn. 2023 Aug-Sep;41(14):6957-6968. doi: 10.1080/07391102.2022.2114014. Epub 2022 Aug 22.
8
Biocatalysis: A smart and green tool for the preparation of chiral drugs.生物催化:手性药物制备的明智绿色工具。
Chirality. 2022 Nov;34(11):1403-1418. doi: 10.1002/chir.23498. Epub 2022 Aug 5.
9
Antimicrobial peptides and their potential application in antiviral coating agents.抗菌肽及其在抗病毒涂层剂中的潜在应用。
Colloids Surf B Biointerfaces. 2022 Sep;217:112693. doi: 10.1016/j.colsurfb.2022.112693. Epub 2022 Jul 8.
10
Liquid-Phase Peptide Synthesis (LPPS): A Third Wave for the Preparation of Peptides.液相肽合成 (LPPS):肽制备的第三波浪潮。
Chem Rev. 2022 Aug 24;122(16):13516-13546. doi: 10.1021/acs.chemrev.2c00132. Epub 2022 Jul 11.